Zoetis Inc. (ZTS)

153,36 +2,48 (+1,64 %) À la clôture : 04:00PM EDT

Zoetis Inc.

10 Sylvan Way
Parsippany, NJ 07054
United States
973 822 7000
https://www.zoetis.com

Secteur(s): Healthcare
Secteur d’activité: Drug Manufacturers - Specialty & Generic
Employés à temps plein: 14 100

Dirigeants clés

Nom	Titre	Payer	Exercé	Année de naissance
Ms. Kristin C. Peck	CEO & Director	3,54M	5,2M	1971
Mr. Wetteny N. Joseph	Executive VP & CFO	1,6M	S.O.	1972
Ms. Wafaa Mamilli	EVP, Chief Digital & Tech. Officer, Group President for China, Brazil and Preci. Animal Health	1,36M	S.O.	1967
Ms. Heidi C. Chen	Employee Advisor	1,24M	S.O.	1967
Dr. Robert J. Polzer Ph.D.	Executive VP and President of Research & Development	1,18M	54,13k	1969
Ms. Roxanne Lagano	EVP, Chief HR Officer & Global Operations, Interim General Counsel and Corporate Secretary	S.O.	S.O.	1965
Mr. Steven Frank	Vice President of Investor Relations	S.O.	S.O.	S.O.
Mr. William Price	VP & Chief Communications Officer	S.O.	S.O.	S.O.
Ms. Jeannette Ferran Astorga	Executive VP of Corporate Affairs & Communications and Chief Sustainability Officer	S.O.	S.O.	1975
Mr. Nick Ashton	Executive VP and President of Global Manufacturing & Supply	S.O.	S.O.	1973

Les montants ont été établis en date du 31 décembre 2023 et les valeurs de compensation concernent le dernier exercice fiscal clos à cette date. Le terme « rémunération » désigne le salaire, les bonus, etc. Le terme « exercé » est utilisé pour la valeur des options exercées au cours de l’exercice fiscal. Devise exprimée en USD.

Description

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.

Gouvernance d’entreprise

L’ISS Governance QualityScore de Zoetis Inc. en date du 1 avril 2024 est 3. Les scores principaux sont Audit : 5; Société : 2; Droits des actionnaires : 7; Compensation : 2.

Résultats de gouvernance d’entreprise offerts par Institutional Shareholder Services (ISS). Les résultats indiquent un rang décile par rapport à l’indice ou à la région. Un résultat décile de 1 indique un risque de gouvernance faible, tandis que 10 indique un risque de gouvernance élevé.